Covance

As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development #CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.

Industry

Research Services

Company size

10,001+ employees

Headquarters

Princeton, New Jersey

Type

Public Company

Specialties

Drug Development Services, Toxicology Services, Central Laboratory Services, Clinical Trial Management Services, Clinical Research, Phase I-IIa, Phase II-III, Preclinical Solutions, Cardiovascular, Oncology, Market Access, Rare Disease, Orphan Drugs, Biotech, Pharmaceuticals, Crop Protection, Clinical Trial Optimization, Market Access, Clinical Trials, Biologics, Cell and Gene Therapy, Pharmacovigilance, NASH, Infectious Diseases, Drug Testing, CRO, Immuno-Oncology, Commercialization, Pediatrics, Kidney Disease, Inflammation, Life Sciences, Bioassays, Bioanalysis, Biologics, Large Molecule, and Small Molecule